InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by ENRIGHT PATRICK G, Director. Insider active across 2 companies, notably Vera Therapeutics, Inc.. Aggregated, 7 filings have been published. Total volume traded: €4.4m. The latest transaction was disclosed on 10 February 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€4m333,333 shares@ €13.13310.12% mcap100.0% of flow
Class A Common Stock
SEC:0000899243-22-013596:0·
Ideal exit: 7 Nov 2022 (T+270)
€235,4042,000 shares@ €117.70190.0016% mcap100.0% of flow
Ordinary Shares
SEC:0001765581-21-000114·
€235,4042,000 shares@ €117.70190.0016% mcap50.0% of flow
Ordinary Shares
SEC:0001765581-21-000114:0·
02,246 shares0
Ordinary Shares
SEC:0001765581-21-000069·
02,246 shares0
Ordinary Shares
SEC:0001765581-21-000069:0·
2,187,504 shares
Class A Common Stock
SEC:0001209191-21-033809·
2,187,504 shares
Class A Common Stock
SEC:0001209191-21-033809:0·
7 of 7 declarations
About ENRIGHT PATRICK G
Enright Patrick G is a Director at Vera Therapeutics, Inc. and Jazz Pharmaceuticals plc. In this role, he is involved in governance and oversight of the company's operations. Patrick brings his expertise in the pharmaceutical sector to contribute to strategic decisions. His commitment to accountability and transparency is essential for the success of the companies.
